123 related articles for article (PubMed ID: 29176703)
1. NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.
Peri S; Izumchenko E; Schubert AD; Slifker MJ; Ruth K; Serebriiskii IG; Guo T; Burtness BA; Mehra R; Ross EA; Sidransky D; Golemis EA
Nat Commun; 2017 Nov; 8(1):1772. PubMed ID: 29176703
[TBL] [Abstract][Full Text] [Related]
2. The T1150A cancer mutant of the protein lysine dimethyltransferase NSD2 can introduce H3K36 trimethylation.
Khella MS; Schnee P; Weirich S; Bui T; Bröhm A; Bashtrykov P; Pleiss J; Jeltsch A
J Biol Chem; 2023 Jun; 299(6):104796. PubMed ID: 37150325
[TBL] [Abstract][Full Text] [Related]
3. NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma.
Brennan K; Shin JH; Tay JK; Prunello M; Gentles AJ; Sunwoo JB; Gevaert O
Sci Rep; 2017 Dec; 7(1):17064. PubMed ID: 29213088
[TBL] [Abstract][Full Text] [Related]
4. Altered gene expression profiles of histone lysine methyltransferases and demethylases in rheumatoid arthritis synovial fibroblasts.
Araki Y; Aizaki Y; Sato K; Oda H; Kurokawa R; Mimura T
Clin Exp Rheumatol; 2018; 36(2):314-316. PubMed ID: 29465369
[TBL] [Abstract][Full Text] [Related]
5. NSD2 is a conserved driver of metastatic prostate cancer progression.
Aytes A; Giacobbe A; Mitrofanova A; Ruggero K; Cyrta J; Arriaga J; Palomero L; Farran-Matas S; Rubin MA; Shen MM; Califano A; Abate-Shen C
Nat Commun; 2018 Dec; 9(1):5201. PubMed ID: 30518758
[TBL] [Abstract][Full Text] [Related]
6. DICER- and MMSET-catalyzed H4K20me2 recruits the nucleotide excision repair factor XPA to DNA damage sites.
Chitale S; Richly H
J Cell Biol; 2018 Feb; 217(2):527-540. PubMed ID: 29233865
[TBL] [Abstract][Full Text] [Related]
7. NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents.
Pan C; Izreig S; Yarbrough WG; Issaeva N
Cancers Head Neck; 2019; 4():3. PubMed ID: 31321084
[TBL] [Abstract][Full Text] [Related]
8. Disruption of
Bui N; Huang JK; Bojorquez-Gomez A; Licon K; Sanchez KS; Tang SN; Beckett AN; Wang T; Zhang W; Shen JP; Kreisberg JF; Ideker T
Mol Cancer Ther; 2018 Jul; 17(7):1585-1594. PubMed ID: 29636367
[TBL] [Abstract][Full Text] [Related]
9. The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck.
Saloura V; Vougiouklakis T; Sievers C; Burkitt K; Nakamura Y; Hager G; van Waes C
Oral Oncol; 2018 Jun; 81():100-108. PubMed ID: 29884408
[TBL] [Abstract][Full Text] [Related]
10. Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer.
Vossen DM; Verhagen CVM; Verheij M; Wessels LFA; Vens C; van den Brekel MWM
Oral Oncol; 2018 Jun; 81():35-44. PubMed ID: 29884412
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases.
Li W; Tian W; Yuan G; Deng P; Sengupta D; Cheng Z; Cao Y; Ren J; Qin Y; Zhou Y; Jia Y; Gozani O; Patel DJ; Wang Z
Nature; 2021 Feb; 590(7846):498-503. PubMed ID: 33361816
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2.
Ferreira de Freitas R; Liu Y; Szewczyk MM; Mehta N; Li F; McLeod D; Zepeda-Velázquez C; Dilworth D; Hanley RP; Gibson E; Brown PJ; Al-Awar R; James LI; Arrowsmith CH; Barsyte-Lovejoy D; Min J; Vedadi M; Schapira M; Allali-Hassani A
J Med Chem; 2021 Feb; 64(3):1584-1592. PubMed ID: 33522809
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
14. PIP4K2B Protein Regulation by NSD1 in HPV-Negative Head and Neck Squamous Cell Carcinoma.
Topchu I; Bychkov I; Roshchina E; Makhov P; Boumber Y
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539515
[TBL] [Abstract][Full Text] [Related]
15. NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma.
Topchu I; Bychkov I; Gursel D; Makhov P; Boumber Y
Cell Death Discov; 2024 Feb; 10(1):75. PubMed ID: 38346948
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.
Huang X; Duijf PHG; Sriram S; Perera G; Vasani S; Kenny L; Leo P; Punyadeera C
J Biomed Sci; 2023 Aug; 30(1):65. PubMed ID: 37559138
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a Machine Learning Model for the Risk Assessment of Perineural Invasion in Head and Neck Squamous Cell Carcinoma.
Weusthof C; Burkart S; Semmelmayer K; Stögbauer F; Feng B; Khorani K; Bode S; Plinkert P; Plath K; Hess J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240283
[TBL] [Abstract][Full Text] [Related]
18. A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment.
Burkart S; Weusthof C; Khorani K; Steen S; Stögbauer F; Unger K; Hess J; Zitzelsberger H; Belka C; Kurth I; Hess J
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980544
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma.
Murali M; Saloura V
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360250
[TBL] [Abstract][Full Text] [Related]
20. Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
Krossa I; Strub T; Aplin AE; Ballotti R; Bertolotto C
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
